Skip to Content

South African firm says it may close its COVID vaccine plant

KIFI

By ANDREW MELDRUM and MARIA CHENG
Associated Press

JOHANNESBURG (AP) — The first factory to produce COVID-19 vaccines in Africa has announced that it has not received enough orders and is planning to stop production within a few weeks, in what a senior World Health Organization official described as a “failure” in efforts to achieve vaccine equity. South Africa’s Aspen Pharmacare said that it cannot let its large-scale sterile manufacturing facilities sit idle and will return to making anesthetics. At the outset of the COVID pandemic, the company shifted its production and achieved capacity to produce more than 200 million doses annually of the one-shot Johnson & Johnson vaccine.  

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content